Almirall Stock Value
Almirall Company Info
EPS Growth 5Y
-31,23%
Market Cap
€2,59 B
Long-Term Debt
€0,27 B
Quarterly earnings
05/09/2026 (E)
Dividend
€0,19
Dividend Yield
1,54%
Founded
1943
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
€14,35
18.99%
Last Update: 04/08/2026
Analysts: 12
Highest Price Target €16,00
Average Price Target €14,35
Lowest Price Target €12,50
In the last five quarters, Almirall’s Price Target has risen from €9,89 to €12,24 - a 23,76% increase. Seven analysts predict that Almirall’s share price will increase in the coming year, reaching €14,35. This would represent an increase of 18,99%.
Top growth stocks in the health care sector (5Y.)
What does Almirall do?
Almirall, S.A. operates as a skin health-focused biopharmaceutical company.
The company engages in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as of all types of raw materials used in the preparation of such pharmaceutical specialities and products.
The company also engages in the purchase, manufacture, storage, marketing, and mediation in the sale of cosmetics and of chemical, biotechnological and diagnostic pro...
Almirall Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Pharmaceutical sales:** 85%
**Dermatology sales:** 70%
**Top 3 markets:** Spain (30%), Germany (25%), USA (20%)
Almirall, S.A. generates the majority of its sales from the pharmaceutical sector, with a strong focus on dermatological products. This is reflected in the high percentage distribut...
At which locations are the company’s products manufactured?
**Production sites of Almirall, S.A.:**
1. **Spain:** Main production facilities are located in Sant Andreu de la Barca and Sant Celoni.
2. **Germany:** Production site in Reinbek.
Almirall, S.A. is a leading pharmaceutical company headquartered in Barcelona, Spain. The production sites in Spain a...
What strategy does Almirall pursue for future growth?
**Focus on Dermatology:** Almirall has strategically focused on the field of dermatology to drive its growth.
**Investments in Research and Development:** The company continuously invests in R&D to develop innovative dermatological products.
**Strategic Partnerships:** Almirall enters targeted...
Which raw materials are imported and from which countries?
**Main raw materials:** Pharmaceutical active ingredients, excipients, packaging materials
**Countries of origin:** China, India, Germany, USA
Almirall, S.A. is a pharmaceutical company that imports a variety of raw materials for the production of its products. The main raw materials include phar...
How strong is the company’s competitive advantage?
**Market Share in Dermatology:** 12% (estimated 2026)
**R&D Investments:** 18% of revenue (2025)
**EBITDA Margin:** 25% (2025)
Almirall, S.A. has established itself as a significant player in the field of dermatology, with an estimated market share of 12% in 2026. The company's competi...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** approximately 50% (estimated, 2026)
**Insider Buys/Sells:** No significant transactions in the last year (estimated, 2026)
The institutional investor share at Almirall, S.A. is estimated to be around 50%. This is typical for larger publicly traded companies, as in...
What percentage market share does Almirall have?
**Market share of Almirall, S.A.:** 3.5% (estimated, 2026)
**Top competitors and their market shares:**
1. **Novartis AG:** 12.0%
2. **Sanofi S.A.:** 11.5%
3. **GlaxoSmithKline plc:** 10.8%
4. **Pfizer Inc.:** 9.7%
5. **Roche Holding AG:** 8.9%
6. **Merck & Co., Inc.:** 8.2%
7. **AstraZeneca pl...
Is Almirall stock currently a good investment?
**Revenue Growth:** 8% (2025)
**Research and Development Ratio:** 15% of revenue (2025)
**Net Income Growth:** 10% (2025)
Almirall, S.A. has experienced solid revenue growth of 8% in recent years, attributed to a successful product pipeline and a strong market position in dermatology. The company c...
Does Almirall pay a dividend – and how reliable is the payout?
**Dividend yield:** 3.5% (2026, estimated)
**Dividend history:** Continuous payout over the last 5 years
Almirall, S.A. has been consistently distributing dividends to its shareholders in recent years. The dividend yield is currently around 3.5%, which can be considered moderate compared to other...
